GB Sciences, Inc.
GBLX · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,628 | $2,239 | $3,057 | $2,579 |
| - Cash | $3 | $2 | $0 | $12 |
| + Debt | $1,994 | $1,869 | $1,759 | $1,759 |
| Enterprise Value | $3,620 | $4,106 | $4,817 | $4,326 |
| Revenue | $97 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $97 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$66 | -$158 | -$254 | -$370 |
| % Margin | -68.3% | – | – | – |
| Net Income | -$100 | -$191 | -$285 | -$467 |
| % Margin | -103.2% | – | – | – |
| EPS Diluted | -0 | -0.001 | -0.001 | -0.001 |
| % Growth | 60% | 28.6% | 41.7% | – |
| Operating Cash Flow | -$355 | -$108 | -$22 | -$252 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$355 | $123 | -$22 | -$252 |